Certified by Founder Lodge
AAVantgarde Bio
Italy - Milan, Lombardy
START UP
1 Disclosed Funding Rounds $65,333,745
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Delivering the next generation gene therapies
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 07 ,2023 | Series A | $65,333,745 |
Atlas Venture
Sofinnova Partners
Forbion
Longwood Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
